Search Results

Filter
  • 1-10 of  530 results for ""Neprilysin""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry.

  • Authors : Stolfo D; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and Univeristy Hospital of Trieste, Trieste, Italy.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/physiopathology ; Stroke Volume*/Stroke Volume*/Stroke Volume*/physiology

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Oct; Vol. 26 (10), pp. 2243-2257. Date of Electronic Publication: 2024 Jul 30.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders.

  • Authors : Alvarez-Perez B; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.; Poras H

Subjects: Neprilysin* ; Opioid-Related Disorders*; Humans

  • Source: British journal of pharmacology [Br J Pharmacol] 2023 Apr; Vol. 180 (7), pp. 879-893. Date of Electronic Publication: 2021 Dec 06.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Radiosynthesis of the 11 C-methyl derivative of LBQ657 for PET investigation of the neprilysin inhibitor sacubitril.

  • Authors : Teyssier VR; Laboratoire de Radiochimie et Cyclotron, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Institut de Génie Biomédical, Faculté de Médecine, Université de Montréal, Québec, Canada.

Subjects: Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/chemical synthesis ; Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/chemical synthesis ; Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/chemistry

  • Source: Journal of labelled compounds & radiopharmaceuticals [J Labelled Comp Radiopharm] 2020 Feb; Vol. 63 (2), pp. 65-71. Date of Electronic Publication: 2020 Jan 08.Publisher: Wiley Country of Publication: England NLM ID: 7610510 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Angiotensin-neprilysin inhibition in de novo heart failure - starting off strong.

  • Authors : Bhatt AS; Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Vaduganathan M

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Neprilysin*; Aminobutyrates/Aminobutyrates/Aminobutyrates/therapeutic use

  • Source: European journal of heart failure [Eur J Heart Fail] 2020 Feb; Vol. 22 (2), pp. 313-314. Date of Electronic Publication: 2019 Dec 16.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.

  • Authors : Nougué H; Inserm UMR-S 942, Lariboisière Hospital, Paris, France.; Department of Anaesthesiology and Intensive Care, Saint-Louis and Lariboisière Hospital, Paris, France.

Subjects: Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use ; Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*therapeutic use ; Atrial Natriuretic Factor/Atrial Natriuretic Factor/Atrial Natriuretic Factor/*metabolism

  • Source: European journal of heart failure [Eur J Heart Fail] 2019 May; Vol. 21 (5), pp. 598-605. Date of Electronic Publication: 2018 Dec 06.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

How does neprilysin inhibition in heart failure work?

  • Authors : Richards AM; Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.; Cardiovascular Research Institute, National University of Singapore, Singapore.

Subjects: Heart Failure* ; Neprilysin*; Aminobutyrates

  • Source: European journal of heart failure [Eur J Heart Fail] 2019 May; Vol. 21 (5), pp. 606-608. Date of Electronic Publication: 2019 Mar 18.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Augmentation of glucagon-like peptide-1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure.

  • Authors : Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA.

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*therapeutic use

  • Source: European journal of heart failure [Eur J Heart Fail] 2018 Jun; Vol. 20 (6), pp. 973-977. Date of Electronic Publication: 2018 Mar 30.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions.

  • Authors : Ambrosy AP; Division of Cardiology, Duke University Medical Center, Durham, NC, USA.; Duke Clinical Research Institute, Durham, NC, USA.

Subjects: Health Knowledge, Attitudes, Practice* ; Practice Guidelines as Topic*; Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*therapeutic use

  • Source: European journal of heart failure [Eur J Heart Fail] 2018 Jun; Vol. 20 (6), pp. 963-972. Date of Electronic Publication: 2018 Feb 21.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization.

  • Authors : Lupón J; Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.

Subjects: Societies, Medical*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Heart Failure/Heart Failure/Heart Failure/*drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2018 May; Vol. 20 (5), pp. 938-940. Date of Electronic Publication: 2017 Sep 26.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.

  • Authors : D'Elia E; Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy.; Iacovoni A

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/metabolism ; Heart Failure*/Heart Failure*/Heart Failure*/physiopathology

  • Source: European journal of heart failure [Eur J Heart Fail] 2017 Jun; Vol. 19 (6), pp. 710-717. Date of Electronic Publication: 2017 Mar 21.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  530 results for ""Neprilysin""